A prospective study of embryos derived from chromosome translocation carriers that have undergone PGD using a novel molecular-based approach.
A reference molecular genetics laboratory specialized in the provision of transport PGD services and a private IVF clinic.
Twenty-seven couples carrying 12 different reciprocal translocations and 2 Robertsonian translocations.
Preimplantation genetic diagnosis from chromosome translocation carriers on blastomeres biopsied from cleavage stage embryos.
Embryo diagnosis rate, pregnancy rate (PR), implantation rate, take-home-baby rate.
Overall, 241/251 (96.0 % ) embryos were successfully diagnosed for chromosome rearrangements. Preimplantation genetic screening was included in the protocol of 12 couples, involving analysis of 90 embryos, 84 (93.3 % ) of which were successfully diagnosed and 53 (63.1 % ) showed aneuploidies. Embryos suitable for transfer were identified in 24 cycles. Eighteen couples achieved a clinical pregnancy (75.0 % PR/embryo transfer), with a total of 31 embryos implanted (59.6 % implantation rate). Ten patients (1 triplet, 1 twin, and 8 singleton pregnancies) have delivered 13 healthy babies, and the other patients (3 twins and 5 singletons) have currently ongoing pregnancies.
The PCR-based PGD protocol for translocations has the potential to overcome several inherent limitations of fluorescence in situ hybridization-based tests, providing potential improvements in terms of test performance, automation, turnaround time, sensitivity, and reliability.